Menu

CME Corner

Active Programs

Strategies for Improving Outcomes in Patients with Parkinson's Disease

Parkinson’s disease (PD) affects roughly one million Americans and more than 10 million people worldwide. It is a progressive neurologic disorder characterized by motor and nonmotor symptoms. Key motor symptoms include resting tremor, bradykinesia, rigidity, and postural instability. Nonmotor symptoms include psychosis, depression, anxiety, impulse control disorders, cognitive impairment, and slee ...

  • Reach MD / podcast Reach MD / podcast
  • ACCME

Clinical Insights in Pediatrics: Type 2 Diabetes in Children and Adolescents with Obesity

The incidence and prevalence of obesity in children and adolescents has increased in recent years, and with it the incidence and prevalence of type 2 diabetes mellitus (T2DM). Compared with adults, T2DM in pediatric patients frequently progresses more rapidly, with high rates of early development of comorbidities and often with a less favorable response to treatment. The American Diabetes Associat ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Update on Psoriatic Arthritis: Best Practices in Rheumatology

Despite numerous advances in treatment for psoriasis and psoriatic arthritis (PsA), many patients continue to experience negative health consequences that could be prevented or improved with optimal evidence-based care. Dermatology, rheumatology, and primary care clinicians can improve outcomes for their patients by increasing their knowledge and competency in diagnosis, management, and interdisci ...

  • Reach MD / podcast Reach MD / podcast
  • ACCME

Update on Psoriasis and Psoriatic Arthritis: Best Practices in Dermatology

Despite numerous advances in treatment for psoriasis and psoriatic arthritis (PsA), many patients continue to experience negative health consequences that could be prevented or improved with optimal evidence-based care. Dermatology, rheumatology, and primary care clinicians can improve outcomes for their patients by increasing their knowledge and competency in diagnosis, management, and interdisci ...

  • Reach MD / podcast Reach MD / podcast
  • ACCME

Optimizing Immunization in IBD: A Quality Improvement Curriculum, Part 1

This activity simulates a quality improvement initiative to illuminate best practices in the immunization of patients with IBD. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Expired Programs

Acute Heart Failure: Current Best Practices, Ongoing Challenges, and Future Directions

Each year, more than 1 million individuals are hospitalized for heart failure (HF). Within the spectrum of HF, acute heart failure (AHF) represents a distinct challenge to clinicians. Diagnosis of AHF is often delayed because of the complex characteristics of the condition. The heterogeneous nature of AHF patients and the presence of comorbid conditions can make it difficult for clinicians to reco ...

  • Online Presentation Online Presentation
  • ACCME

Clinical Insights in Pediatrics: Diagnosing and Managing Pediatric Epilepsy

In the United States, an estimated 460,000 children have active epilepsy, and approximately 750,000 children have a history of epilepsy. Epilepsy is a complex disorder that requires careful monitoring and management. Newer pharmacologic options for the treatment of focal and generalized seizures may provide more effective treatment options in the pediatric population. In addition to managing epile ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Clinical Insights in Pediatrics: Improving Asthma Control by Optimizing Pharmacotherapy, Monitoring, and Patient Education

Millions of children and their families are affected by asthma, the most common chronic illness of childhood and the third leading cause of hospitalization among children under the age of 15. Pediatricians and pediatric nurse practitioners are uniquely positioned to care for children and adolescents with asthma, as they are heavily involved in the assessment, management, and follow-up of these pat ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Identifying and Managing Patients with IBD at Risk for Progressive Disease

Treatment strategies for IBD vary depending on disease type, severity, and patient risk profile. This activity will examine severity and risk assessment, guideline recommended treatment, and patient communication strategies. ...

  • Online Presentation Online Presentation
  • ACCME

Improving the Management of Depression in Primary Care: Insights into Diagnosis and Treatment (Program ID 16052200)

Major depressive disorder (MDD) is one of the most common mental disorders diagnosed in the United States, with an estimated 16% of US adults experiencing MDD at some point during their lifetimes. According to the American Medical Association, chronic depression is often untreated and, on average, patients with depression receive the recommended quality of care only 58% of the time. The goal of th ...

  • Online Presentation Online Presentation
  • AANP

Motivational Interviewing to Support Shared Decision Making in MS
First Question: Should I Start Treatment?

This activity, the first in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the practice of motivational interviewing (MI) and how it can help clinicians prompt patients to think about their diagnosis and therapeutic options. The management of MS is increasingly challenging due to the wide variation in the clinical course for each patient, an increas ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Patient-Centered Care in Advanced Prostate Cancer

Recommended treatment options for prostate cancer vary based on disease severity and life expectancy, with traditional approaches including active surveillance, surgery, radiation therapy, chemotherapy, and androgen deprivation therapy (ADT). Prostate cancer that progresses despite ADT is known as castration-resistant prostate cancer (CRPC). Until recently, the standard of care for CRPC patients w ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Psoriatic Arthritis: Understanding the Patient Experience to Improve Patient Satisfaction and Outcomes

The validated tools to assess PsA severity often do not capture what patients consider to be most important/challenging about their disease. To effectively engage patients when developing treatment plans, clinicians need information about the patients’ individual experiences with, perceptions of, and beliefs about PsA. In this “Rate the Quality” activity, you will meet three patients and rate the ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Shared Decision Making at the Crossroads: Adjusting MS Therapy Next Question: When Is it Time to Adjust Therapy?

This activity, the third in a 3-part series focused on shared decision making and patient-centered care in MS, will examine how to assess outcomes of DMT therapy from both patient and clinician perspectives, as well as practical strategies for working with patients to adjust therapy when necessary. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Shared Decision Making in Selecting Initial MS Disease-Modifying Therapy
Next Question: Which Disease-Modifying Therapy Should I Try First?

This activity, the second in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the differences in MS disease-modifying therapies (DMT) and provide guidance for working together with patients to select appropriate first-line treatment. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Stroke Prevention in Atrial Fibrillation: Current Evidence for Tailoring Antithrombotic Therapy (Program ID: 15111981)

Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 million people in the United States. AF is an independent risk factor for ischemic stroke severity, recurrence, and mortality. Individuals with AF have a 4 to 5 times greater risk for ischemic stroke. The National Stroke Association emphasizes the importanc ...

  • Online Presentation Online Presentation
  • AANP

Stroke Prevention in Atrial Fibrillation: Tailoring Anticoagulation Therapy for Optimal Outcomes

A CPE-certified interactive newsletter with highlights from the American Society of Consultant Pharmacists workshop. Although most AF-related strokes can be prevented with anticoagulation medication, many older adults are not receiving optimal evidence-based therapy for stroke prevention. This activity will address persistent barriers to the appropriate use of anticoagulation therapy for the p ...

  • i-Newsletter i-Newsletter
  • ACPE

Targeting B-Cell Lymphomas: The Latest Updates in Therapies, Practice Strategies, and Clinical Research

The standards of care in treatment for non-Hodgkin lymphomas (NHL) are evolving as new therapies receive FDA approval and new evidence provides insight into optimal evidence-based approaches. Several key cellular pathways that drive malignant B-cell development have recently been identified and validated, leading to the development of therapies targeting these pathways. Agents targeting the B-cell ...

  • Online Presentation Online Presentation
  • ACCME

The Evolving Migraine Paradigm: Improving Diagnostic Accuracy

Migraine is underdiagnosed, frequently misdiagnosed, undertreated, and/or improperly managed, leading to reduced health-related quality of life, increased risk of psychiatric and medical comorbidities, and increased headache-related burden. This activity will improve clinicians' ability to diagnose migraine, resulting in improved outcomes for patients. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

The Evolving Migraine Paradigm: Tailoring Treatment

Migraine is underdiagnosed and frequently misdiagnosed, undertreated, and/or improperly managed, leading to reduced health-related quality of life, increased risk of psychiatric and medical comorbidities, and increased headache-related burden. This activity will improve clinicians' ability to manage migraine in adult patients, resulting in improved outcomes for patients. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 1: Diagnosis and Initial Treatment Options

Inflammatory bowel disease (IBD) can be challenging to diagnose because of its heterogeneous and somewhat ambiguous clinical presentation. Despite the challenges, primary care clinicians are on the front line for assessment and initial diagnosis of these patients. Once diagnosed, even if placed under the care of a gastroenterologist, these patients will require life-long care. This activity, the f ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 2: Escalating Therapy, Addressing Treatment Risks, and Co-Managing With Specialists

Patients with inflammatory bowel disease (IBD) who present with moderate to severe disease, or who relapse after treatment for mild disease will often require treatment with additional forms of therapy. Primary care clinicians are on the front line for monitoring their patients for treatment response and adverse events. This activity, the second in a 3-part series, addresses escalation of therapy ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Treatment Patterns in Family Medicine: The Role of the Primary Care Clinician in Patient-Centered Management of IBD/Module 3: Improving Adherence, Monitoring, and Communication

Inflammatory bowel disease is commonly associated with a wide range of extraintestinal manifestations that may appear in a variety of locations throughout the body. This activity, the third in a 3-part series, will review these manifestations and the primary care clinician’s role in identifying/investigating them. It will also examine patient non-adherence to medication and offer suggestions for f ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Updates on Molecular Testing in NSCLC

Oncologists have new options when treating advanced NSCLC. The use of molecular profiling to define subgroups of patients most likely to experience clinical benefit from novel targeted therapies has been endorsed by both ASCO and the National Comprehensive Cancer Network (NCCN).This activity will examine the role of molecular biomarkers in patients with advanced NSCLC. ...

  • Mobile + Online on QuantiaMD
  • ACCME
Main Menu
EDITOR'S PICKS